Suppression of myoclonus in SCA2 by piracetam. - Wikidata - wikimedia - TriplyDB

Suppression of myoclonus in SCA2 by piracetam.

Suppression of myoclonus in SCA2 by piracetam.

http://www.wikidata.org/entity/Q46692041

about

Movement disorders in spinocerebellar ataxias.The Multiple Faces of Spinocerebellar Ataxia type 2.Cerebrotendinous xanthomatosis: the effectiveness of high-dose piracetam for the treatment of cerebellar and sensorial ataxia.

P2860

Q37849252-A5E82234-5041-4DD1-92FF-44C471E7EAB0 Q41510206-B62652F5-2D6F-4DC5-AB91-89EEC0601D46 Q48624667-FA35A074-1F46-4CE9-BCBD-3562ABAC127A

P2860

Suppression of myoclonus in SCA2 by piracetam.

http://www.wikidata.org/entity/Q46692041

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Suppression of myoclonus in SCA2 by piracetam.

@en

Suppression of myoclonus in SCA2 by piracetam.

@nl

type

label

Suppression of myoclonus in SCA2 by piracetam.

@en

Suppression of myoclonus in SCA2 by piracetam.

@nl

prefLabel

Suppression of myoclonus in SCA2 by piracetam.

@en

Suppression of myoclonus in SCA2 by piracetam.

@nl

P1433

Q46692041-127D6087-0353-4FE4-AF35-E660E32B7113

P1476

Q46692041-430C89C6-BCDC-4C81-8AF6-B7D357741E7C

P2093

Q46692041-1D7DE000-E932-41F2-9F31-2F72EF57EE7D

Q46692041-2BDC2A66-FBCE-4104-9EFD-CF1566C65B34

Q46692041-3AA34A07-6288-4B56-93CC-0FE8ED9AC075

Q46692041-4FA642CF-F05A-4B0C-849F-2BD1C76A1D58

Q46692041-60E12CC7-2A86-4E75-9152-A6C223CD8598

Q46692041-62016A46-5A74-45D8-B3AD-B26EB5ADBF55

Q46692041-77A523C7-419E-41B5-A924-476CC09A09E8

Q46692041-8DE3408F-D59D-4082-B4DB-1EA804EB97AA

Q46692041-C2CC09C9-2F5B-4162-ADF0-AA165259C7F5

P304

Q46692041-341BF842-2848-4873-968A-574E13642F88

P31

Q46692041-75C4E56A-42C2-493D-8CBA-FF493CBF8E4C

P356

Q46692041-8D4F132D-44FC-4C75-A3CF-498691C90A67

P407

Q46692041-0792FC9D-A53B-41C4-8A7F-EB8E6AE6978F

P433

Q46692041-FFE76848-4A7A-4237-B4AF-DDB194A3665B

P478

Q46692041-33058C0A-8119-45A0-B898-A917DCB24371

P577

Q46692041-31526B21-0838-45C1-8BFB-40961E3ED1AE

P698

Q46692041-6B06381F-66C4-475E-B4F9-3AD33072F0B9

P356

P1433

Movement Disorders

P1476

Suppression of myoclonus in SCA2 by piracetam.

@en

P2093

Alessandro Filla

http://www.w3.org/2001/XMLSchema#string

Anna De Rosa

http://www.w3.org/2001/XMLSchema#string

Arturo de Falco

http://www.w3.org/2001/XMLSchema#string

Carlo Rinaldi

http://www.w3.org/2001/XMLSchema#string

Fabrizio Barbieri

http://www.w3.org/2001/XMLSchema#string

Giuseppe De Michele

http://www.w3.org/2001/XMLSchema#string

Pasquale Striano

http://www.w3.org/2001/XMLSchema#string

Salvatore Striano

http://www.w3.org/2001/XMLSchema#string

Tecla Tucci

http://www.w3.org/2001/XMLSchema#string

P304

116-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.20683

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16149096

http://www.w3.org/2001/XMLSchema#string